This case looks at an otherwise healthy 59-year-old man who was recently diagnosed with clinical stage IVB prostate adenocarcinoma. What is the most appropriate management for this patient?
Thomas J. Pugh, MD
Advertisement
Articles by Thomas J. Pugh, MD
A 62-year-old man with prostate adenocarcinoma elected to proceed with radical prostatectomy as definitive management. After his pathology report showed stage IIIB disease, he elected for observation. What happened next?
Advertisement
Latest Updated Articles
Post-Prostatectomy Radiation Therapy: Patient Selection, Timing, Imaging, and Therapy IntensificationPublished: July 15th 2018 | Updated:
The Role of Primary Tumor Treatment and Metastasis-Directed Therapy in Oligometastatic Prostate CancerPublished: May 14th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC
2
Lifileucel Confers Durable Responses in Pretreated Advanced NSCLC Type
3
EDIC Displays Continuous Evolution as Variable in EOT Grade 3 Lymphopenia
4
How Can Oncology Staffing Shortages Be Remedied?
5
